The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medifast Inc

NYSE: MED
Last

(U.S.) $31.97

Today's change-0.86 -2.62%
Updated June 24 4:02 PM EDT. Delayed by at least 15 minutes.
 

Medifast Inc

NYSE: MED
Last

(U.S.) $31.97

Today's change-0.86 -2.62%
Updated June 24 4:02 PM EDT. Delayed by at least 15 minutes.

Medifast Inc down (U.S.)$0.86

Medifast Inc closed sharply lower Friday, dropping (U.S.)$0.86 or 2.62% to (U.S.)$31.97. Shares have lost 1.27% over the last five days, but have gained 5.23% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $32.07
  • Previous close(U.S.) $32.83
  • High(U.S.) $32.49
  • Low(U.S.) $31.74
  • Bid / Ask-- / --
  • YTD % change+5.23%
  • Volume280,351
  • Average volume (10-day)100,242
  • Average volume (1-month)201,135
  • Average volume (3-month)137,254
  • 52-week range(U.S.) $26.14 to (U.S.) $35.32
  • Beta0.81
  • Trailing P/E19.80×
  • P/E 1 year forward17.91×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.00
  • Dividend yield3.13%
  • Trailing EPS(U.S.) $1.62
Updated June 24 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.14%

Based on its net profit margin of 7.14%, Medifast Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.69%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue72616672
Total other revenue--------
Total revenue72616672
Gross profit53454953
Total cost of revenue19161719
Total operating expense66565863
Selling / general / administrative47404145
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income6689
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax6689
Income after tax4456
Income tax, total2233
Net income4466
Total adjustments to net income--------
Net income before extra. items4456
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4456
Inc. avail. to common incl. extra. items4466
Diluted net income4466
Dilution adjustment--0----
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.360.330.450.48
Dividends per sharevalue per share0.250.250.000.00
Diluted normalized EPSvalue per share0.360.330.450.48